{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "9858672", "DateCompleted": {"Year": "1999", "Month": "03", "Day": "15"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0027-5107", "JournalIssue": {"Volume": "438", "Issue": "1", "PubDate": {"Year": "1999", "Month": "Jan", "Day": "02"}}, "Title": "Mutation research", "ISOAbbreviation": "Mutat Res"}, "ArticleTitle": "Evaluation of 8-oxodeoxyguanosine, typical oxidative DNA damage, in lymphocytes of ozone-treated arteriosclerotic patients.", "Pagination": {"StartPage": "23", "EndPage": "27", "MedlinePgn": "23-7"}, "Abstract": {"AbstractText": ["In the present study we measured the amount of 8-oxo-2'-deoxyguanosine (8-oxo-dG) in DNA isolated from lymphocytes of arteriosclerotic patients undergoing ozonetherapy. Treatment of the patients with therapeutic concentration of ozone caused a significant increase over the control value in the amount of 8-oxo-dG of DNA isolated from their lymphocytes. However, only three out of six patients examined responded positively to the treatment in terms of the base damage. The increases varied among patients, and were in the range of 100-450%. This interindividual difference may at least be partly explained by recently demonstrated heritable susceptibility to ozone."], "CopyrightInformation": "Copyright 1999 Elsevier Science B.V."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, The Ludwik Rydygier Medical University in Bydgoszcz, ul. Karlowicza 24, 85-092, Bydgoszcz, Poland."}], "Identifier": [], "LastName": "Foksinski", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bialkowski", "ForeName": "K", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Skiba", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ponikowska", "ForeName": "I", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Szmurlo", "ForeName": "W", "Initials": "W"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Olinski", "ForeName": "R", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mutat Res", "NlmUniqueID": "0400763", "ISSNLinking": "0027-5107"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "88847-89-6", "NameOfSubstance": "8-Hydroxy-2'-Deoxyguanosine"}, {"RegistryNumber": "G9481N71RO", "NameOfSubstance": "Deoxyguanosine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "8-Hydroxy-2'-Deoxyguanosine"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["therapy"], "DescriptorName": "Arteriosclerosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA Damage"}, {"QualifierName": ["analogs & derivatives", "analysis"], "DescriptorName": "Deoxyguanosine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lymphocytes"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["genetics"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "12", "Day": "22"}, {"Year": "1998", "Month": "12", "Day": "22", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "12", "Day": "22", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9858672", "10.1016/s1383-5718(98)00155-7", "S1383-5718(98)00155-7"]}}], "PubmedBookArticle": []}